Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,254 | 272 | 96.3% |
| Education | $204.55 | 13 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $945.57 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $850.52 | 43 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $548.00 | 24 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $318.42 | 20 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $264.32 | 12 | $0 (2024) |
| Travere Therapeutics, Inc. | $193.01 | 10 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $177.32 | 10 | $0 (2019) |
| AKEBIA THERAPEUTICS INC | $173.62 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $146.31 | 10 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $146.09 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,318 | 58 | Amgen Inc. ($269.25) |
| 2023 | $913.09 | 43 | AstraZeneca Pharmaceuticals LP ($322.45) |
| 2022 | $671.03 | 37 | Aurinia Pharma U.S., Inc. ($122.35) |
| 2021 | $703.40 | 40 | AstraZeneca Pharmaceuticals LP ($221.44) |
| 2020 | $383.08 | 25 | AstraZeneca Pharmaceuticals LP ($127.59) |
| 2019 | $424.48 | 26 | Amgen Inc. ($116.97) |
| 2018 | $517.96 | 30 | OPKO Pharmaceuticals, LLC ($123.01) |
| 2017 | $527.05 | 26 | Amgen Inc. ($139.46) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: NEPHROLOGY | ||||||
| 12/18/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Nephrology | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $86.05 | General |
| Category: NEPHROLOGY | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.19 | General |
| 11/07/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: NEPHROLOGY | ||||||
| 10/24/2024 | Amgen Inc. | Aranesp (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Nephrology | ||||||
| 10/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $27.04 | General |
| 10/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $15.89 | General |
| Category: NEPHROLOGY | ||||||
| 09/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Inflammation | ||||||
| 08/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.09 | General |
| Category: NEPHROLOGY | ||||||
| 08/12/2024 | Amgen Inc. | Aranesp (Biological), TAVNEOS | Food and Beverage | In-kind items and services | $37.27 | General |
| Category: Nephrology | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.28 | General |
| 07/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 725 | 1,169 | $216,425 | $99,773 |
| 2022 | 15 | 795 | 1,355 | $242,761 | $110,770 |
| 2021 | 14 | 893 | 1,471 | $237,602 | $116,387 |
| 2020 | 14 | 975 | 1,876 | $371,038 | $166,007 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 34 | 97 | $53,410 | $26,198 | 49.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 63 | $31,510 | $14,154 | 44.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 157 | $19,625 | $9,593 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 139 | $19,460 | $9,039 | 46.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 74 | 150 | $19,500 | $8,153 | 41.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 109 | 209 | $17,765 | $8,035 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 167 | $19,205 | $7,654 | 39.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $11,275 | $5,252 | 46.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $5,320 | $2,851 | 53.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 18 | 44 | $6,600 | $2,821 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,990 | $2,168 | 54.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 30 | 31 | $4,805 | $1,953 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 24 | $3,960 | $1,902 | 48.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 37 | 118 | $64,900 | $32,463 | 50.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 31 | 56 | $27,725 | $12,855 | 46.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 77 | 181 | $23,530 | $10,182 | 43.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 185 | $23,125 | $10,026 | 43.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 65 | $17,875 | $9,545 | 53.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 109 | 274 | $23,290 | $7,997 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 164 | $18,860 | $7,502 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 110 | $15,400 | $6,495 | 42.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 70 | $11,550 | $5,430 | 47.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 37 | 38 | $5,890 | $2,826 | 48.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $2,850 | $1,465 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,730 | $1,434 | 52.5% |
About Dr. Paul Delyria, M.D
Dr. Paul Delyria, M.D is a Nephrology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1457690125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Delyria, M.D has received a total of $5,458 in payments from pharmaceutical and medical device companies, with $1,318 received in 2024. These payments were reported across 285 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,254).
As a Medicare-enrolled provider, Delyria has provided services to 3,388 Medicare beneficiaries, totaling 5,871 services with total Medicare billing of $492,937. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Grand Rapids, MI
- Active Since 01/31/2013
- Last Updated 10/29/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1457690125
Products in Payments
- LOKELMA (Drug) $501.39
- JYNARQUE (Drug) $488.43
- Parsabiv (Biological) $328.71
- TAVNEOS (Drug) $319.48
- ACTHAR (Biological) $272.36
- LUPKYNIS (Drug) $264.32
- FARXIGA (Drug) $260.97
- Auryxia (Drug) $181.26
- JARDIANCE (Drug) $170.44
- RAYALDEE (Drug) $154.82
- Rayaldee (Drug) $147.82
- Kerendia (Drug) $146.31
- TARPEYO (Drug) $146.09
- Veltassa (Drug) $118.93
- BENLYSTA (Biological) $104.67
- Parsabiv (Drug) $98.86
- Aranesp (Biological) $93.91
- Tavneos (Drug) $85.36
- Rituxan (Biological) $80.54
- INJECTAFER (Drug) $78.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Grand Rapids
Dr. Ronald Hofmann, Md, MD
Nephrology — Payments: $10,254
Dr. James Visser, Md, MD
Nephrology — Payments: $3,813
Dr. Brett Plattner, M.d, M.D
Nephrology — Payments: $3,647
Dr. Daniel Legault, Md, MD
Nephrology — Payments: $3,145
Dr. Ramandeep Banga, M.d, M.D
Nephrology — Payments: $2,281
Dr. Kseniya Filippova, Md, MD
Nephrology — Payments: $2,016